Stroke prevention in atrial fibrillation changes after dabigatran availability in China: The GLORIA‐AF registry
Article 2020 en
Authors
CM
Changsheng Ma
LF
Lionel Riou França
SL
Shihai Lu
Abstract
1 min read
There was an increase in OAC and decrease in antiplatelet agent prescription since dabigatran availability in China. However, a large proportion of AF patients at risk for stroke remained untreated.
Е. V. Shlyakhto, S. V. Villevalde, Andrey Ezhov, S. A. Zenin, Н. А. Козиолова, О. Yu. Korennova, Т. N. Novikova, К. В. Протасов, G. Yu. Chumakova, Christine Teutsch, Shihai Lu, Professor Gregory Lip, Menno V. Huisman
Е. V. Shlyakhto, S. V. Villevalde, Andrey Ezhov, S. A. Zenin, Н. А. Козиолова, О. Yu. Korennova, Т. N. Novikova, К. В. Протасов, G. A. Chumakova, Christine Teutsch, Shihai Lu, Professor Gregory Lip, Menno V. Huisman
William F. McIntyre, David Conen, Brian Olshansky, Jonathan L. Halperin, Emil Hayek, Menno V. Huisman, Professor Gregory Lip, Shihai Lu, Jeff S. Healey
Sake J. van der Wall, Christine Teutsch, Sérgio Dubner, Hans‐Christoph Diener, Jonathan L. Halperin, Chang Sheng, Kenneth J. Rothman, Miney Paquette, Kristina Zint, Lionel Riou França, Shihai Lu, Professor Gregory Lip, Menno V. Huisman
Discussion(0)
No comments yet. Be the first to comment.